Induction of partial specific heterotypic immunity in mice by a single infection with influenza a virus, J Bacteriol, vol.89, pp.170-174, 1965. ,
Heterosubtypic immunity to influenza in ferrets, Infect Immun, vol.29, pp.650-653, 1980. ,
Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection, Journal of General Virology, vol.82, issue.11, pp.2697-2707, 2001. ,
DOI : 10.1099/0022-1317-82-11-2697
Cross-Reactive, Cell-Mediated Immunity and Protection of Chickens from Lethal H5N1 Influenza Virus Infection in Hong Kong Poultry Markets, Journal of Virology, vol.75, issue.6, pp.2516-2525, 2001. ,
DOI : 10.1128/JVI.75.6.2516-2525.2001
Control of influenza virus infection by immunity to conserved viral features, Expert Review of Anti-infective Therapy, vol.1, issue.4, pp.627-638, 2003. ,
DOI : 10.1586/14787210.1.4.627
Cross???Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine, The Journal of Infectious Diseases, vol.196, issue.9, pp.1313-1320, 2007. ,
DOI : 10.1086/521304
The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak, Bull Word Health Organ, vol.20, pp.297-301, 1959. ,
Prior H1N1 Influenza Infection and Susceptibility of Cleveland Family Study Participants during the H2N2 Pandemic of 1957: An Experiment of Nature, The Journal of Infectious Diseases, vol.193, issue.1, pp.49-53, 2006. ,
DOI : 10.1086/498980
Heterosubtypic immunity to influenza A virus: where do we stand?, Microbes and Infection, vol.10, issue.9, pp.1024-1029, 2008. ,
DOI : 10.1016/j.micinf.2008.07.002
Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans, PLoS Medicine, vol.41, issue.2, 2007. ,
DOI : 10.1371/journal.pmed.0040059.g005
Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial, The Lancet, vol.362, issue.9400, pp.1959-1966, 2003. ,
DOI : 10.1016/S0140-6736(03)15014-3
Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine, New England Journal of Medicine, vol.354, issue.13, pp.1343-1351, 2006. ,
DOI : 10.1056/NEJMoa055778
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells, PLoS ONE, vol.81, issue.12, 2008. ,
DOI : 10.1371/journal.pone.0003942.s001
Antibody Recognition of a Highly Conserved Influenza Virus Epitope, Science, vol.324, issue.5924, 2009. ,
DOI : 10.1126/science.1171491
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses, Nature Structural & Molecular Biology, vol.371, issue.3, pp.265-273, 2009. ,
DOI : 10.1038/nsmb.1566
Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle-based serological assay, Journal of Clinical Virology, vol.47, issue.1 ,
DOI : 10.1016/j.jcv.2009.10.009
URL : https://hal.archives-ouvertes.fr/pasteur-00561333
Immunogenicity and Safety of Intradermal Influenza Immunization at a Reduced Dose in Healthy Children, PEDIATRICS, vol.119, issue.6, pp.1076-1082, 2007. ,
DOI : 10.1542/peds.2006-3176
URL : https://hal.archives-ouvertes.fr/pasteur-00589024
Immune response to influenza vaccination in community-dwelling Chinese elderly persons, Vaccine, vol.24, issue.25, pp.5371-5380, 2006. ,
DOI : 10.1016/j.vaccine.2006.04.032
Hemagglutinin pseudotyped lentiviral particles: Characterization of a new method for avian H5N1 influenza sero-diagnosis, Journal of Clinical Virology, vol.39, issue.1, pp.27-33, 2007. ,
DOI : 10.1016/j.jcv.2007.02.005
URL : https://hal.archives-ouvertes.fr/pasteur-00589029
The possible effects of aggregation of the molecules of hemoglobin on its dissociation curves, J Physiol (Lond.), vol.40, pp.4-7, 1910. ,
Studies of H5N1 Influenza Virus Infection of Pigs by Using Viruses Isolated in Vietnam and Thailand in 2004, Journal of Virology, vol.79, issue.16, pp.10821-10825, 2005. ,
DOI : 10.1128/JVI.79.16.10821-10825.2005
Safety and immunogenicity of an inactivated split-virion influenza A/VietnamH5N1) vaccine: phase I randomised trial, Lancet, vol.1194, issue.367, pp.1657-1664, 2004. ,
An Adjuvanted, Low???Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross???Reactive Immune Responses in Healthy Adults, The Journal of Infectious Diseases, vol.198, issue.5, pp.642-649, 2008. ,
DOI : 10.1086/590913
Antibody Response in Individuals Infected with Avian Influenza A (H5N1) Viruses and Detection of Anti???H5 Antibody among Household and Social Contacts, The Journal of Infectious Diseases, vol.180, issue.6, pp.1763-1770, 1999. ,
DOI : 10.1086/315137
Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens, PLoS ONE, vol.80, issue.6, 2008. ,
DOI : 10.1371/journal.pone.0002517.t002
Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets, PLoS Medicine, vol.80, issue.1, 2009. ,
DOI : 10.1371/journal.pmed.1000049.s006
Crossprotective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses, Plos Pathogens, vol.5, 2009. ,
Universal epitopes of influenza virus hemagglutinins?, Nature Structural & Molecular Biology, vol.7, issue.3, pp.233-234, 2009. ,
DOI : 10.1038/nsmb.1574
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies, Proceedings of the National Academy of Sciences, vol.105, issue.16, pp.5986-5991, 2008. ,
DOI : 10.1073/pnas.0801367105
Low Frequency of Poultry-to-Human H5N1 Transmission, Southern Cambodia, 2005, Emerging Infectious Diseases, vol.12, issue.10, pp.1542-1547, 2005. ,
DOI : 10.3201/eid1210.060424
Update on avian influenza A (H5N1) virus infection in humans, WHO. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, pp.261-273, 2008. ,